دورية أكاديمية
أعرض في EDS

Phytochemistry, Toxicology, and Pharmacological Properties of Origanum elongatum .

التفاصيل البيبلوغرافية
العنوان: Phytochemistry, Toxicology, and Pharmacological Properties of Origanum elongatum .
المؤلفون: Abdelaali B; Laboratory of Biodiversity, Ecology and Genome, Mohammed V University in Rabat, Rabat, Morocco., El Menyiy N; Laboratory of Physiology, Pharmacology and Environmental Health, University Sidi Mohamed Ben Abdellah, Fez, Morocco., El Omari N; Laboratory of Histology, Embryology, and Cytogenetic, Mohammed V University in Rabat, Rabat, Morocco., Benali T; Environment and Health Team, Polydisciplinary Faculty of Safi, Cadi Ayyad University, Marrakech, Morocco., Guaouguaou FE; Mohammed V University in Rabat, LPCMIO, Materials Science Center (MSC), Ecole Normale Supérieure, Rabat, Morocco., Salhi N; Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, BP 6203, Rabat, Morocco., Naceiri Mrabti H; Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, BP 6203, Rabat, Morocco., Bouyahya A; Laboratory of Human Pathologies Biology, Department of Biology, Mohammed V University in Rabat, Rabat, Morocco.
المصدر: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2021 Jun 17; Vol. 2021, pp. 6658593. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub Country of Publication: United States NLM ID: 101215021 Publication Model: eCollection Cited Medium: Print ISSN: 1741-427X (Print) Linking ISSN: 1741427X NLM ISO Abbreviation: Evid Based Complement Alternat Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2011- : New York, NY : Hindawi Pub.
Original Publication: Oxford, UK : Oxford University Press, c2004-
مستخلص: Origanum elongatum L. is an endemic aromatic and medicinal plant. This work reports previous studies on O. elongatum concerning its taxonomy, botanical description, geographical distribution, bioactive compounds, toxicology, and biological effects. Chemical analyses showed that O. elongatum contains different chemical compounds, in particular volatile compounds. Pharmacological investigations showed that volatile compounds and extracts from O. elongatum exhibit different pharmacological properties, such as antibacterial, antifungal, antiviral, antioxidant, vasodilator, corrosion inhibitor, and hepatoprotective effects. Moreover, toxicological reports revealed the safety of this species. The pharmacological effects of O. elongatum could be correlated with the main compounds, which exhibit different pharmacological properties with numerous mechanism insights.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2021 Balahbib Abdelaali et al.)
References: Phytomedicine. 2018 Jun 1;45:41-48. (PMID: 29573911)
J Immunotoxicol. 2016;13(2):157-64. (PMID: 25812626)
J Oleo Sci. 2010;59(8):415-21. (PMID: 20625233)
Biochem Biophys Res Commun. 2017 Aug 5;489(4):432-438. (PMID: 28571740)
J Ethnopharmacol. 2001 Aug;76(3):201-14. (PMID: 11448540)
Food Chem. 2017 Nov 15;235:127-135. (PMID: 28554616)
Eur J Pharmacol. 2018 Aug 15;833:210-220. (PMID: 29883671)
J Food Drug Anal. 2016 Jul;24(3):556-563. (PMID: 28911561)
J Immunotoxicol. 2011 Oct-Dec;8(4):265-73. (PMID: 21711089)
Microb Pathog. 2020 Apr;141:103980. (PMID: 31962183)
J Ethnopharmacol. 2016 Feb 17;179:22-6. (PMID: 26721216)
Parasitol Res. 2010 Apr;106(5):1205-15. (PMID: 20217133)
Food Chem. 2014 May 1;150:307-12. (PMID: 24360455)
Eur J Pharmacol. 2015 Aug 15;761:279-87. (PMID: 26007642)
J Pharm Pharmacol. 2019 Nov;71(11):1725-1733. (PMID: 31523814)
Exp Parasitol. 2012 May;131(1):20-4. (PMID: 22417972)
Phytomedicine. 2002 Dec;9(8):721-6. (PMID: 12587692)
Food Cosmet Toxicol. 1967 Apr;5(2):141-57. (PMID: 6068552)
Parasitol Res. 2008 Jul;103(2):259-61. (PMID: 18438729)
Evid Based Complement Alternat Med. 2018 Sep 3;2018:4573254. (PMID: 30250490)
J Lipid Res. 2010 Jan;51(1):132-9. (PMID: 19578162)
Arch Pharm Res. 2009 Jan;32(1):75-8. (PMID: 19183879)
Evid Based Complement Alternat Med. 2016;2016:3012462. (PMID: 28090211)
Eur J Pharmacol. 2013 Sep 5;715(1-3):46-55. (PMID: 23838456)
Biomed Res Int. 2017;2017:1681392. (PMID: 29181386)
Mol Cell Biochem. 2014 Jan;385(1-2):23-31. (PMID: 24057121)
IUBMB Life. 2019 Jan;71(1):9-19. (PMID: 30308112)
Int J Biol Macromol. 2019 Mar 15;125:1069-1074. (PMID: 30552929)
J Pain. 2010 Nov;11(11):1222-9. (PMID: 20452289)
Anticancer Drugs. 2015 Sep;26(8):813-23. (PMID: 26214321)
Planta Med. 2010 Sep;76(13):1411-8. (PMID: 20157878)
J Pharmacol Exp Ther. 2007 Mar;320(3):1163-70. (PMID: 17138864)
تواريخ الأحداث: Date Created: 20210705 Latest Revision: 20231107
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8225437
DOI: 10.1155/2021/6658593
PMID: 34221086
قاعدة البيانات: MEDLINE
الوصف
تدمد:1741-427X
DOI:10.1155/2021/6658593